HORMONAL CONTRACEPTIVES: BENEFITS AND RISKS OF THEIR USE BY THE FEMALE POPULATION

被引:0
|
作者
Moreira, Karolaine de Aguiar [1 ]
de Jesus, Jociel Honorato [2 ]
Geron, Vera Lucia Matias G. [3 ]
Nunes, Jucelia da Silva [4 ]
机构
[1] Ctr Univ Faema UNIFAEMA, Grad Farm, Ariquemes, Rondonia, Brazil
[2] Univ Fed Rondonia UNIR, Ctr Univ Faema UNIFAEMA, Porto Velho, Rondonia, Brazil
[3] Univ Fed Para UFPA, Ctr Univ Faema UNIFAEMA, Belem, Para, Brazil
[4] Ctr Univ Faema UNIFAEMA, Fac Ciencias Biomed Cacoal FACIMED, Ariquemes, Rondonia, Brazil
关键词
Hormonal contraceptives; risks; benefits; fharmaceutical advice;
D O I
10.31072/rcf.v13i2.1139
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
Since the 1960s, hormonal contraceptives have been an advance in family planning for women, being the reversible method of contraception in order to prevent unwanted pregnancies. Hormonal methods of contraception, such as oral, injectable, transdermal and intrauterine, have similar aspects, with risks and benefits in their use. For this reason, this work aims to present the main methods of hormonal contraceptives addressing their benefits and risks of use as a primary method by the female population. The methodology used in this study refers to a descriptive and exploratory literature review. Synthetic contraceptive hormones have a similar effect to female hormones in the gestational period, keeping progesterone and estrogen levels constant, regardless of the hormonal contraceptive method used, all of which have the main objective of preventing an unwanted pregnancy. With the use of these methods as primary, among the benefits found the treatment of endometriosis and the convenience of use according to the method of choice stand out among the benefits, among the risks are thrombolytic events and myocardial infarction, which can be avoided with use of pharmaceutical guidance. Finally, it is observed that the female population needs guidance on hormonal methods in order to minimize damage and eradicate their use irrationally, ensuring adherence, in addition to therapeutic efficacy.
引用
收藏
页码:45 / 80
页数:36
相关论文
共 50 条
  • [1] HORMONAL CONTRACEPTIVES - BENEFITS AND RISKS
    BRECKWOLDT, M
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1989, 49 (06) : 521 - 522
  • [3] The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives
    Shulman, Lee P.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (04) : S9 - S13
  • [4] The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives
    Burke, Anne E.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (04) : S14 - S17
  • [5] BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use
    Grandi, Giovanni
    Monari, Francesca
    Sola, Valentina Boggio
    Cortesi, Laura
    Toss, Angela
    del Savio, Maria Chiara
    Melotti, Chiara
    Centurioni, Maria Grazia
    Gustavino, Claudio
    Varesco, Liliana
    Facchinetti, Fabio
    Barra, Fabio
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2022, 27 (06): : 439 - 444
  • [6] RISKS OF THE HORMONAL CONTRACEPTIVES
    LAURITZEN, C
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1983, 125 (49): : 1141 - 1143
  • [7] Perception about benefits and risks related to combined hormonal contraceptives use in women with Lynch syndrome
    Barra, Fabio
    Perrone, Umberto
    Ferrero, Simone
    Bogliolo, Stefano
    Ottonello, Silvia
    Gustavino, Claudio
    Iasci, Angela
    Grandi, Giovanni
    Pulliero, Alessandra
    Centurioni, Maria Grazia
    Izzotti, Alberto
    [J]. ANNALS OF MEDICINE, 2024, 56 (01)
  • [8] Predictors of adherence to hormonal contraceptives in a female veteran population
    Kazerooni, Rashid
    Takizawa, Atsuhiko
    Vu, Khanh
    [J]. CONTRACEPTION, 2014, 89 (04) : 292 - 298
  • [9] Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks
    Brynhildsen, Jan
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2014, 5 (05) : 201 - 213
  • [10] Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits
    Dokras, Anuja
    [J]. FERTILITY AND STERILITY, 2016, 106 (07) : 1572 - 1579